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VITAMIN A
The beneficial effects of vitamin A might have
been recognized by the ancient Egyptians, who
treated eye disease with raw liver (1). They recog-
nized a connection between eye problems and the
liver, which is the richest source of dietary vitamin
A. On the other hand, foods of vegetable origin do
not have vitamin A, but provitamins for the forma-
tion of vitamin A do occur in abundance in many
vegetable foods (2). These are yellow and red ca-
rotenoid pigments, which, because they have chemi-
cal structures similar to that of vitamin A, can be
changed into vitamin A during intestinal absorption.
The well-known basic function of vitamin A is the
formation of the retinal pigments of the eye. How-
ever, today, we know that vitamin A (retinol) and its
biologically active derivatives, the retinoids (the most
potent of which is all-trans-retinoic acid (RA)), regu-
late key processes such as inhibition of cell prolifera-
tion, differentiation, apoptosis, shaping of the em-
bryo, and organogenesis (3). Vitamin A deficiency
causes congenital malformations of the eye, heart,
gonads, and lungs. In both youths and adults, lack
of vitamin A impairs growth, vision, reproduction,
and homeostasis of several organs. Active metabo-
lites of vitamin A can prevent and cure a majority of
these defects. In addition, retinoids have anti-cancer
properties, as illustrated by their efficacy in the treat-
ment of promyelocytic leukemia (3).
The wide spread nature of the bioactivities of
retinoids is due, in large part, to the ability of reti-
noids to regulate the expression of target genes. It is
now well established that retinoids regulates genes
which control neural differentiation, neurite out-
growth, and the patterning of the anteroposterior
axis of the neural tube (4, 5). And more recently,
evidence has emerged that retinoid signaling may
also be required for neural aspects of adults brain
function (6).
RETINOID RECEPTORS
The actions of vitamin A’s metabolites are primar-
ily mediated by nuclear retinoid receptor proteins
termed retinoic acid receptors (RAR-alpha, -beta,
and -gamma) and retinoid ‘‘X’’ receptors (RXR-
alpha, -beta, and -gamma). These receptors aremem-
bers of the steroid receptor family and essentially
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they function as transcription factors. The RAR and
RXR exist and work forming heterodimers with each
other, or with other nuclear receptors such as thy-
roid hormone receptors, vitamin D receptors, and
the peroxisome proliferation activated receptor. The
RAR and RXR, as with all nuclear receptors, contain
a DNA-binding and ligand-binding domains. The
ligand specificities of these receptors differ. RAR
bind RA with high affinity and 9-cis-RA with lower
affinity, whereas RXR bind 9-cis-RA (7). The effects
of Vitamin A and its derivatives on gene transcrip-
tion are presumed to be mediated largely by RA in-
teractions with RAR since 9-cis-RA is undetectable
in any tissues in vivo (8). Activation of the RAR-RXR
heterodimer is controlled by RAR because RXR-
selective ligands do not induce gene transcription, a
phenomenon termed ‘‘RAR dominance’’ (9). How-
ever, once an RAR ligand is bound, RXR ligands can
increase the transcriptional efficiency of the RAR-
RXR heterodimer (10).
The distinct temporal and spatial expression pat-
tern of each retinoid receptor subtype and isoform
suggests that they each may regulate specific neu-
ronal phenomena. Only two of the RAR, RARalpha
and RARbeta, are detected at high levels in the adult
brain with RARgamma expression being very low.
RARalpha protein has a fairly widespread distribu-
tion with particularly high levels in the hippocam-
pus and cortex (11). On the other hand, RARbeta
and RXRgamma have a more restricted distribution
including dopamine-innervated areas such as the
caudate/putamen and nucleus accumbens (11). The
distribution of the RAR indicates the potential for
several areas of the adult brain to respond to reti-
noids. Indeed, studies performed in the mice hav-
ing RAR and RXR double mutantation demonstrate
that this is the case. Impaired long-term potentiation
and long-term depression, cellular mechanisms un-
derlying memory and learning, have been demon-
strated in mice lacking for RARbeta alone, or both
RARbeta and gamma (12). On the other hand, in
RARbeta-RXRbeta or RARbeta-RXRgamma double
null mutant mice, reduced forward locomotion and
rearing frequency was observed in the open field
test (13). Mutants involving either RARalpha or
RARgamma alone, or RARalpha-RXRgamma com-
bination did not show any defects in locomotor
tests, suggesting a specifity of the retinoid signal-
ing pathways, with respect to RARbeta, RXRbeta
and RXRgamma, is involved in regulating move-
ment. In addition to the locomotor deficit, the ex-
pression of the dopamine D1 and D2 receptors was
decreased 40% in the striatum of RARbeta-RXRbeta
and RARbeta-RXRgamma null mice, but not in
RARbeta or RXRgamma single mutants (13).
SLEEP REGULATION
Humans spend approximately one third of their
lives to sleeping, but the purpose of this ubiquitous
behavior remains to be clarified. The overpowering
nature of sleep and the fact that restful awake peri-
ods do not satisfy the need for sleep has led to the
suggestion that the purpose of sleep involves main-
tenance and repair of central neurons (14). For this
maintenance and repair to occur, it appears that a
difference in brain activity is required, that is, the
slow, delta oscillation (2 Hz in human,  4 Hz in
mice) in electroencephalogram (EEG) observed
during deep sleep.
Slow wave sleep (SWS) is known to be a deep
sleep defined by EEG delta oscillation. SWS is also
referred to as non rapid eye movement (NREM)
sleep (stage 3 and 4). The power of the delta oscil-
lation is a reliable parameter for an assessment of
sleep depth and homeostatic need for sleep (15).
The delta power depends on prior waking (16). It
is well-known that sleep deprivation (SD), that is,
forced wakefulness, causes a large increase in the
delta power. This homeostatic mechanism of sleep
is thought to have an essential role for rest and
maintenance of neural function. Tononi and Cirelli
have suggested that the homeostatic regulation of
the delta power in sleep is linked with synaptic po-
tentiation and rescaling (17, 18). It is hypothesized
that the increased density of synapse during wake-
fulness is arranged and downscaled during SWS.
Furthermore, Huber, et al. have demonstrated that
a local increase in the delta oscillation in sleep af-
ter a motor learning task correlates with improved
performance in humans (19). However, the neural
and/or molecular mechanisms in generation of the
delta oscillation remain unclear.
RETINOIC ACID RECEPTOR AND SLEEP
REGULATION
We performed SD experiment with mice in order
to see the change of gene expression in the brain
relating with sleep loss using cDNA microarray (un-
published data). We found only one gene which was
significantly increased, that is transthyretin (Fig. 1).
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Transthyretin has a critical role as a transporter pro-
tein for retinol. On the other hand, Maret, et al. re-
cently reported that the gene encoding the RAR de-
termines the contribution of the delta oscillation in
the sleep EEG in mice (20). Changes in the relative
contribution of delta oscillations to the SWS EEG
are linked to RARbeta gene and more specifically
to RARbeta1. These results raise the possibility that
vitamin A (retinol and its derivatives) is involved
in the regulation of the delta oscillation.
EXPERIMENT OF VITAMIN A DEFICIENCY
(21, 22)
In order to clarify the linkage between vitamin A
and the delta oscillation, we attempted to record
the sleep EEG and behavior in mice fed a vitamin
A-deficient (VAD) diet.
1. Sleep scoring and delta power in NREM sleep
Figure 2 shows representative EEGs and their
power spectra during each stage (Wake, NREM
and REM) in VAD and control mice respectively.
The EEG consisted mainly of the delta frequency
range in control mice during NREM sleep. On the
other hand, in VAD mice, the EEG oscillation be-
came faster and the delta power was lower than con-
trol mice (Fig. 2B). During both Wake and REM
sleep, EEG patterns and power spectra were un-
largely modified in VAD mice (Figs. 2A and 2C).
The circadian profile of sleep/wake for 24 h was also
affected unlargely by VAD (Fig. 3).
The hourly averaged power of the delta oscillation
in NREM sleep differed significantly between VAD
and control mice throughout 24 h (Fig. 4A). The av-
eraged delta power for 24 h was significantly lower
in VAD than in control mice (Fig. 4B). Figure 5
shows the recovery of the delta power in VAD mice
for one week after the replacement of diet from VAD
to normal. The feeding of the normal diet induced
a significant recovery of EEG delta power in VAD.
A B C
Fig. 2 Representative EEGs during Wake (A), NREM (B) and REM sleep (C) in four-week VAD and control mice and their power
spectra (from ref.22). The EEG oscillation became faster in VAD mice compared with control mice in NREM sleep. Power spectrum
showed the decrease of power in the delta frequency range (4 Hz) in VAD mice. Note that the amplitude of EEG is almost the
same. In Wake and REM sleep, EEG patterns and power spectra were quite similar between VAD and control mice. We defined NREM
sleep in VAD mice by the increase of amplitude of EEG and the attenuation of EMG.
Fig. 1 cDNA microarray comparing genes expression between
with and without 6-h sleep deprivation.
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AB
Fig. 5 The changes of percentage of delta power in VAD mice
(n =4) by the replacement of diet from VAD to control (A) (from
ref.22). Just after baseline recording (filled circle), VAD diet was
replaced with the control diet containing vitamin A (1.2 μg reti-
nol/g). Each data point represents the meanS.E.M. Delta
power was significantly recovered by 1-week control diet feed-
ing. In the 7th day (gray line), the averaged power spectrum in
NREM sleep recorded from 14 : 00 h-15 : 00 h showed the in-




Fig. 4 Twenty-four hour time course change in the percentage
(A) and averaged percentage of the delta power in NREM sleep
(B) in VAD (filled circles and bars ; n =6) and control (open cir-
cles and bars ; n =6) mice (from ref.22). Each data point repre-
sents the meanS.E.M. The delta power was decreased signifi-
cantly in VAD mice compared with control mice. **P0.01.
A
B
Fig. 3 Twenty-four hour time course changes in the amounts of Wake, NREM and REM sleep (A) and each total amount for 24 h
(B) in VAD (filled circles and bars ; n=6) and control (open circles and bars ; n =6) mice (from ref.22). Each data point represents the
meanS.E.M. REM sleep was increased significantly in VAD mice. *P0.05.
H. Sei Vitamin A and sleep regulation4
2. Spontaneous activity
Circadian changes in spontaneous locomotor ac-
tivity during 24 h differed significantly between VAD
and control mice (Fig. 6A). Total spontaneous activ-
ity decreased significantly in VAD mice (Fig. 6B)
compared with control mice.
3. Sleep deprivation
Figure 7 shows the effect of 6 -h SD on the delta
power in VAD and control mice. Before SD, the
analysis of variance (ANOVA) showed a significant
difference between VAD and control mice. After SD,
the significance level became lower, and the aver-
aged percentage of the delta power was no longer
significantly different between VAD mice and con-
trol mice after SD.
A
B
Fig. 6 The results of twenty-four hour recording of spontane-
ous locomotor activity (A) and total spontaneous activity over
24 h (B) in VAD (filled circles and bar ; n =6) and control (open
circles and bar ; n =6) mice (from ref.22). Each data point rep-
resents the meanS.E.M. The VAD mice showed a significant




Fig. 7 Time course change of the percentage of delta power be-
fore and after sleep deprivation (SD) (A) and each averaged per-
centage of the delta power (B) (filled circles and bars ; n =7) and
control (open circles and bars ; n =6) mice (from ref.22). Each
data point represents the meanS.E.M. SD was started at the be-
ginning of the light phase (8 : 00) and continued for 6 h. Note
that the difference of the delta power between VAD and control
mice is diminished after SD. The averaged power spectra inNREM
sleep recorded during the first hour after SD (gray line) and
during the same clock time before SD (black line) also indicate
the recovery of delta power by SD in VAD mice (C). *P0.05.
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4. Level of striatal monoamines
We then quantified the striatal monoamines by
high performance liquid chromatography to ex-
plore the effect of VAD on dopaminergic function.
There was a significant difference between VAD
and control mice in the dihydroxyphenylacetic acid
(DOPAC) level (Fig. 8).
In the VAD experiments, we have found that
VAD causes the attenuation in the delta oscilla-
tion, locomotor activity and striatal DOPAC levels.
It is considered that diminished dopaminergic ac-
tivity caused by VAD may induces the decrease of
locomotor activity. We carried out a 6-h SD to clar-
ify the relationship between sleep homeostasis and
VAD. Six-hour SD caused the recovery of the delta
power in VAD mice to the level observed in the con-
trol mice. This result indicates that the mechanism
for generation of the delta wave seems not to be
impaired by VAD, and prolonged waking periods
can recover the delta wave even in VAD mice. It
has been reported that significant deprivation of vi-
tamin A and its metabolites is very difficult to in-
duce in mice, because mice pups are born with suf-
ficient vitamin A stores to last till their entire lives
(4). In fact, although the level of plasma retinol was
significantly decreased in our VAD mice, the differ-
ence was not so large. Furthermore, we have found
that transthyretin, carrier protein for retinol, is in-
creased by the SD (unpublished data). It is there-
fore possible that SD procedure may induce the ad-
ditional outflow of vitamin A from the stock in the
liver, resulting the recovery of delta oscillation. Al-
though it still remains to be clear whether the ef-
fect of VAD is direct or indirect, vitamin A or its me-
tabolites is considered to be involved in sleep ho-
meostasis.
PERSPECTIVE
Today, we have several antagonists for RARs and
RXRs. For example, LE540 is a RAR pan-antagonist
(23), and HX531 is a RXR pan-antagonist (24). Us-
ing these antagonists, we should verify the role of
RA on the sleep regulation.
Recently, we have found an interesting paper
stating that decrease of transthyretin is one of the
causes for impairment of memory function by age-
ing, because the supplement of retinoic acid, which
does not need for help of transthyretin, improves
the memory function (25). This finding raises the
possibility that the impairment of sleep architecture
by ageing, such as decrease of SWS and/or REM
sleep duration, may also be induced by the decease
of transthyretin. One of our ongoing studies is there-
fore on the effect of retinoic acid or agonists for ret-
inoic acid receptors on sleep homeostasis in the
model mice of ageing.
Fig. 8 The amount of striatal monoamines in VAD (filled bars ;
n=8) and control (open bars ; n =8) mice (from ref.22). Each data
point represents the meanS.E.M. The amount of DOPAC in
VAD mice was significantly lower than that in control mice. The
differences between groups in dopamine and 5-HT did not reach
the significant level. *P0.05.
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